SKI Market

Indian Indices

Nifty

24,768.35 -86.70
(-0.35%)

Sensex

80,842.85 -342.73
( -0.42%)

Bank Nifty

55,961.95 -188.75
( -0.34%)

Nifty IT

35,301.65 -180.05
( -0.51%)

Global Indices

Nasdaq

44,167.41 -314.88
(-0.71%)

Dow Jones

6,364.11 -19.79
(-0.31%)

Hang Seng

40,837.80 -232.02
(-0.56%)

Nikkei 225

9,132.81 -4.13
(-0.05%)

Forex

USD-INR

87.43 0.51
(0.59%)

EUR-INR

100.57 0.11
(0.10%)

GBP-INR

116.43 0.45
(0.39%)

JPY-INR

0.59 0.00
(0.53%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

59.9703537

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

57.04

3986.53

EPS(TTM)

Face Value()

Div & Yield %

6.97

0.03

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	806.67	690.62	779.16	487.70	378.84	350.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	806.67	690.62	779.16	487.70	378.84	350.77
Other Income	2.18	2.57	3.10	3.73	5.79	4.17
Stock Adjustments	-0.57	33.39	19.39	-14.29	10.91	-13.77
Total Income	808.28	726.58	801.65	477.14	395.54	341.17
EXPENDITURE :
Raw Materials	389.32	365.21	431.35	236.00	190.45	167.00
Power & Fuel Cost	17.79	15.24	11.00	9.94	8.23	3.43
Employee Cost	109.63	86.73	85.61	66.22	58.59	46.85
Other Manufacturing Expenses	28.43	24.67	27.42	18.20	15.93	21.15
Selling & Administrative Expenses	104.31	87.99	77.97	45.93	54.08	46.29
Miscellaneous Expenses	10.75	9.51	17.16	13.20	10.35	6.29
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	660.22	589.36	650.51	389.49	337.63	291.01
Operating Profit	148.05	137.22	151.14	87.65	57.90	50.16
Interest	15.36	8.22	5.37	13.63	13.91	10.16
Gross Profit	132.69	129.00	145.77	74.02	43.99	40.00
Depreciation	17.02	22.28	18.93	16.31	13.86	4.65
Profit Before Tax	115.67	106.72	126.84	57.71	30.13	35.35
Tax	26.37	28.21	32.15	17.20	8.31	11.53
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	3.17	-1.19	-1.15	-3.72	-0.87	1.88
Reported Net Profit	86.14	79.70	95.84	44.23	22.69	21.94
Extraordinary Items	-1.67	0.02	0.05	0.02	0.01	0.03
Adjusted Net Profit	87.81	79.68	95.79	44.21	22.68	21.91
Adjustment below Net Profit	0.00	0.00	0.00	0.26	0.00	0.39
P & L Balance brought forward	267.29	188.55	93.68	49.58	27.36	44.11
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.97	0.97	0.97	0.39	0.47	0.47
P & L Balance carried down	352.46	267.29	188.55	93.68	49.58	65.98
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	10.00	10.00	5.00	5.00
Dividend Per Share(Rs)	0.10	0.10	0.10	0.10	0.05	0.05
Earnings Per Share-Unit Curr	8.59	8.22	9.89	4.56	2.34	2.82
Earnings Per Share(Adj)-Unit Curr	8.59	8.22	9.89	4.56	2.34	2.82
Book Value-Unit Curr	53.11	35.88	27.76	17.89	13.34	9.68
Book Value(Adj)-Unit Curr	53.11	35.88	27.76	17.89	13.34	9.68

24,768.35 -86.70 (-0.35%)

80,842.85 -342.73 ( -0.42%)

55,961.95 -188.75 ( -0.34%)

35,301.65 -180.05 ( -0.51%)

44,167.41 -314.88 (-0.71%)

6,364.11 -19.79 (-0.31%)

40,837.80 -232.02 (-0.56%)

9,132.81 -4.13 (-0.05%)

87.43 0.51 (0.59%)

100.57 0.11 (0.10%)

116.43 0.45 (0.39%)

0.59 0.00 (0.53%)